| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/03/1996 | EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof |
| 07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
| 07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 07/03/1996 | CN1125581A Scorpion-and -ant oral liquid and its preparation method |
| 07/02/1996 | US5532245 To reduce smooth muscle contractions; treatment for urinary incontinence, iritable bowel syndrome |
| 07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
| 06/26/1996 | EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent |
| 06/26/1996 | EP0717774A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 06/26/1996 | EP0717739A1 Bicyclic aromatic compounds as therapeutic agents |
| 06/26/1996 | CN1125451A Biologically active vasopressin analogues |
| 06/26/1996 | CN1125133A Tonglinling medicine |
| 06/25/1996 | US5530019 For treatment of prostate gland disorders |
| 06/25/1996 | US5530017 Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids |
| 06/25/1996 | US5530009 Treating asthma |
| 06/20/1996 | WO1996004241A3 Benzoylguanidine derivatives as medicaments |
| 06/19/1996 | EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss |
| 06/19/1996 | EP0716648A1 New 9-chloro-prostaglandin derivatives |
| 06/19/1996 | EP0716607A1 Biochemically balanced peritoneal dialysis solutions |
| 06/19/1996 | CN1124926A Pyrazolopyrimidinones for the treatment of impotence |
| 06/19/1996 | CN1124923A Endothelin receptor antagonists |
| 06/19/1996 | CN1124643A Tablet for nephritis |
| 06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
| 06/18/1996 | US5527821 For treatment of urinary incontinence |
| 06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
| 06/13/1996 | WO1996017953A2 Genetic basis of factor xiii activity |
| 06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | WO1996017831A1 Uracil derivatives |
| 06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
| 06/12/1996 | EP0716087A1 Heterocyclic amides for control of the potassium channels |
| 06/12/1996 | EP0715627A1 Indole derivatives as thromboxane a2 antagonists |
| 06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
| 06/11/1996 | US5525614 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
| 06/11/1996 | US5525604 4-aminopyrimidine derivatives |
| 06/11/1996 | CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
| 06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 06/06/1996 | WO1996016657A1 Bicyclic heterocyclic compounds for the treatment of impotence |
| 06/06/1996 | WO1996016644A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
| 06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/06/1996 | CA2164375A1 Heterocyclic amides |
| 06/05/1996 | EP0714894A1 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists |
| 06/05/1996 | EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist |
| 06/05/1996 | EP0714300A1 Methods for modulating the human sexual response |
| 06/05/1996 | CN1123682A Kidney-nourishing and bone-strengthening pill and its preparation |
| 06/04/1996 | US5523298 Used to induce labor, abortion, menstruation, and againsts hormonal irregularities |
| 06/04/1996 | US5523094 Aqueous mixture of alfuzosin, organic solvent and absorption promoter |
| 06/02/1996 | CA2161209A1 3-<1,2,3,6-tetrahydro-<1-alkylenearyl>-4-pyridinyl>- and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-ht1f agonists |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/29/1996 | EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them |
| 05/29/1996 | EP0713653A1 Fortified fruit juice |
| 05/29/1996 | CN1123545A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells |
| 05/29/1996 | CA2163840A1 Potentiation of drug response |
| 05/28/1996 | US5521315 Olefin substituted long chain compounds |
| 05/28/1996 | US5521216 Treating complications of diabetes |
| 05/28/1996 | US5521213 Nonsteroid antiinflammatory agents |
| 05/28/1996 | US5521206 Hypotensive agents, treatment of atherosclerosis |
| 05/28/1996 | US5521197 Analgesics using serotonin antagonist |
| 05/28/1996 | US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome |
| 05/28/1996 | US5521173 Tricyclic benzazepine vasopressin antagonists |
| 05/28/1996 | US5521170 Benzamide derivatives and pharmaceutical composition comprising the same |
| 05/25/1996 | CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/24/1996 | CA2163466A1 Fortified fruit juices |
| 05/23/1996 | WO1996015103A1 Diaminocyclobutene-3,4-diones |
| 05/23/1996 | WO1996014880A1 Method and apparatus for interstitial radiation of the prostate gland |
| 05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | WO1996014846A1 Dihydropyrimidines and uses thereof |
| 05/23/1996 | WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS |
| 05/23/1996 | WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents |
| 05/22/1996 | EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 05/22/1996 | EP0521914B1 A method for regulating neuron development and maintenance |
| 05/21/1996 | US5519138 Angiotensin antagonist |
| 05/21/1996 | US5518733 Cosmetic compositions containing oligosaccharides |
| 05/17/1996 | WO1996014410A1 Human scf, a splice variant thereof, its pharmaceutical use |
| 05/17/1996 | WO1996014339A1 Antibodies |
| 05/17/1996 | WO1996014316A1 A method of treating urinary bladder dysfunctions |
| 05/17/1996 | WO1996014300A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities |
| 05/17/1996 | WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/17/1996 | WO1996014066A1 A method of treating urinary bladder dysfunctions |
| 05/15/1996 | EP0711757A1 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists |
| 05/15/1996 | EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 05/15/1996 | EP0711289A1 Piperazine compounds used in therapy |
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0711168A1 Methods of treating apoptosis and associated conditions |
| 05/15/1996 | EP0711157A1 Endothelin receptor antagonists |
| 05/15/1996 | CN1122248A Insulin analog formulations |
| 05/15/1996 | CN1122246A Snow Ganoderma lucidum oral liquid |
| 05/15/1996 | CN1122245A Snow Ganoderma lucidum solid medicament |
| 05/14/1996 | US5516774 Treating diseases characterized by excess renal reabsorption of water |
| 05/14/1996 | US5516771 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 05/14/1996 | US5516764 Anti-inflammatory agent |
| 05/14/1996 | US5516653 Genetic engineering |
| 05/09/1996 | CA2162089A1 ¬3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy|-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists |
| 05/08/1996 | EP0710657A1 Antagonists of adhesion receptors |